Drug Profile
TCM-based therapy for coronary disorders - China Pharma Holdings
Alternative Names: TCM for coronary heart disease - China Pharma Holdings; Traditional Chinese Medicine - China Pharma HoldingsLatest Information Update: 23 Dec 2019
Price :
$50
*
At a glance
- Originator China Pharma Holdings
- Class Vascular disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Coronary disorders